Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer
CLINICAL CANCER RESEARCH (2008)
Journal
CLINICAL CANCER RESEARCH
Volume 14, Issue 11, Pages 3494-3502Publisher
AMER ASSOC CANCER RESEARCH
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Low TINAGL1 expression is a marker for poor prognosis in breast cancer
Akiko Kato, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Tomoka Hisada, Yasuaki Uemoto, Mitsuo Terada, Hiroyuki Kato, Masayuki Komura, Katsuhiro Okuda, Satoru Takahashi, Tatsuya Toyama
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)
PTGES3 is a Putative Prognostic Marker in Breast Cancer
Adeseye Adekeye, Divyansh Agarwal, Anupma Nayak, Julia Tchou
JOURNAL OF SURGICAL RESEARCH (2022)
INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer
Huda Razvi, Julia Y. Tsang, Ivan K. Poon, Siu-Ki Chan, Sai-Yin Cheung, Ka-Ho Shea, Gary M. Tse
PATHOLOGY (2021)
A novel PTEN mutant caused by polymorphism in cis-regulatory elements is involved in chemosensitivity in breast cancer
Jing Wang, Shasha Zhang, Jiaxin Zhang, Zhongliang Zhang, Qinglong Ma, Wenkang Fu, Xiaohua Chen, Dapeng Zhao, Meie Zhao, Cuixia Di, Xiaodong Xie
AMERICAN JOURNAL OF CANCER RESEARCH (2023)
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer
Marina Ciscar, Eva M. Trinidad, Gema Perez-Chacon, Mansour Alsaleem, Maria Jimenez, Maria J. Jimenez-Santos, Hector Perez-Montoyo, Adrian Sanz-Moreno, Andrea Vethencourt, Michael Toss, Anna Petit, Maria T. Soler-Monso, Victor Lopez, Jorge Gomez-Miragaya, Clara Gomez-Aleza, Lacey E. Dobrolecki, Michael T. Lewis, Alejandra Bruna, Silvana Mouron, Miguel Quintela-Fandino, Fatima Al-Shahrour, Antonio Martinez-Aranda, Angels Sierra, Andrew R. Green, Emad Rakha, Eva Gonzalez-Suarez
EMBO MOLECULAR MEDICINE (2023)
Cyclin C: A new responser for chemosensitivity in cancer
Shuai Fang, Xiaofeng Jin, Chengwei Zhou, Zhaohui Gong
CLINICAL AND TRANSLATIONAL MEDICINE (2022)
Wnt Family Member 9b (Wnt9b) Is a New Sensitive and Specific Marker for Breast Cancer
Shaolei Lu, Evgeny Yakirevich, Dongfang Yang, Ying Xiao, Li Juan Wang, Yihong Wang
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
NEUROD1 predicts better prognosis in pancreatic cancer revealed by a TILs-based prognostic signature
Zhiyang Jiang, Jiadong Pan, Jiahui Lu, Jie Mei, Rui Xu, Dandan Xia, Xuejing Yang, Huiyu Wang, Chaoying Liu, Junying Xu, Junli Ding
FRONTIERS IN PHARMACOLOGY (2022)
Circulating methylated THBS1 DNAs as a novel marker for predicting peritoneal dissemination in gastric cancer
Xuan-Yu Hu, Zhe-Nan Ling, Lian-Lian Hong, Qi-Ming Yu, Pei Li, Zhi-Qiang Ling
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
Low RAI2 expression is a marker of poor prognosis in breast cancer
Sayaka Nishikawa, Yasuaki Uemoto, Tae-Sun Kim, Tomoka Hisada, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Yusuke Katagiri, Mitsuo Terada, Akiko Kato, Yu Dong, Hiroshi Sugiura, Katsuhiro Okuda, Hiroyuki Kato, Satoshi Osaga, Satoru Takahashi, Tatsuya Toyama
BREAST CANCER RESEARCH AND TREATMENT (2021)
Immune-Related Genes to Construct a Novel Prognostic Model of Breast Cancer: A Chemosensitivity-Based Study
Zhi-Min Deng, Wei Hu, Fang-Fang Dai, Meng-Qin Yuan, Min Hu, Yan-Xiang Cheng
FRONTIERS IN IMMUNOLOGY (2021)
KMT5A-methylated SNIP1 promotes triple-negative breast cancer metastasis by activating YAP signaling
Bo Yu, Jun Su, Qiqi Shi, Qing Liu, Jun Ma, Guoqing Ru, Lei Zhang, Jian Zhang, Xichun Hu, Jianming Tang
NATURE COMMUNICATIONS (2022)
Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
Chrysostomi Gialeli, Emre Can Tuysuz, Johan Staaf, Safia Guleed, Veronika Paciorek, Matthias Morgelin, Konstantinos S. Papadakos, Anna M. Blom
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation
Rongrong Wu, Arya Mariam Roy, Yoshihisa Tokumaru, Shipra Gandhi, Mariko Asaoka, Masanori Oshi, Li Yan, Takashi Ishikawa, Kazuaki Takabe
CANCERS (2022)
Tumour budding is a novel marker in breast cancer: the clinical application and future prospects
Ting Huang, Hui Bao, Yu-hua Meng, Jian-lin Zhu, Xiao-dong Chu, Xiao-li Chu, Jing-hua Pan
ANNALS OF MEDICINE (2022)
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study
Ashley Weir, Eun-Young Kang, Nicola S. Meagher, Gregg S. Nelson, Prafull Ghatage, Cheng-Han Lee, Marjorie J. Riggan, Aleksandra Gentry-Maharaj, Andy Ryan, Naveena Singh, Martin Widschwendter, Jennifer Alsop, Michael S. Anglesio, Matthias W. Beckmann, Jessica Berger, Christiani Bisinotto, Jessica Boros, Alison H. Brand, James D. Brenton, Angela Brooks-Wilson, Michael E. Carney, Julie M. Cunningham, Kara L. Cushing-Haugen, Cezary Cybulski, Esther Elishaev, Ramona Erber, Sian Fereday, Anna Fischer, Luis Paz-Ares, Javier Gayarre, Blake C. Gilks, Marcel Grube, Paul R. Harnett, Holly R. Harris, Arndt Hartmann, Alexander Hein, Joy Hendley, Brenda Y. Hernandez, Sabine Heublein, Yajue Huang, Tomasz Huzarski, Anna Jakubowska, Mercedes Jimenez-Linan, Catherine J. Kennedy, Felix K. F. Kommoss, Jennifer M. Koziak, Bernhard Kraemer, Nhu D. Le, Jaime Lesnock, Jenny Lester, Jan Lubinski, Janusz Menkiszak, Britta Ney, Alexander Olawaiye, Sandra Orsulic, Ana Osorio, Luis Robles-Diaz, Matthias Ruebner, Mitul Shah, Raghwa Sharma, Yurii B. Shvetsov, Helen Steed, Aline Talhouk, Sarah E. Taylor, Nadia Traficante, Robert A. Vierkant, Chen Wang, Lynne R. Wilkens, Stacey J. Winham, Javier Benitez, Andrew Berchuck, David D. Bowtell, Francisco J. Candido dos Reis, Linda S. Cook, Anna DeFazio, Jennifer A. Doherty, Peter A. Fasching, Maria J. Garcia, Ellen L. Goode, Marc T. Goodman, Jacek Gronwald, David G. Huntsman, Beth Y. Karlan, Stefan Kommoss, Francesmary Modugno, Joellen M. Schildkraut, Hans-Peter Sinn, Annette Staebler, Linda E. Kelemen, Caroline E. Ford, Usha Menon, Paul D. P. Pharoah, Martin Koebel, Susan J. Ramus, D. Bowtell, A. DeFazio, N. Traficante, S. Fereday, A. Brand, P. Harnett, R. Sharma
BRITISH JOURNAL OF CANCER (2023)
Assessing the risk of cervical neoplasia in the post-HPV vaccination era
Matti Lehtinen, Ville N. Pimenoff, Belinda Nedjai, Karolina Louvanto, Lisanne Verhoef, Danielle A. M. Heideman, Mariam El-Zein, Martin Widschwendter, Joakim Dillner
INTERNATIONAL JOURNAL OF CANCER (2023)
Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts
Silvia Stacchiotti, Hans Roland Duerr, Inga-Marie Schaefer, Klaus Woertler, Rick Haas, Annalisa Trama, Augusto Caraceni, Jyoti Bajpai, Giacomo Giulio Baldi, Nicholas Bernthal, Jean-Yves Blay, Kjetil Boye, Javier-Martin Broto, Wei-Wu Tom Chen, Paolo Angelo Dei Tos, Jayesh Desai, Stephan Emhofer, Mikael Eriksson, Alessandro Gronchi, Hans Gelderblom, Jendrik Hardes, Wolfgang Hartmann, John Healey, Antoine Italiano, Robin L. Jones, Akira Kawai, Andreas Leithner, Herbert Loong, Eric Mascard, Carlo Morosi, Nadine Otten, Emanuela Palmerini, Shreyaskumar R. Patel, Peter Reichardt, Brian Rubin, Piotr Rutkowski, Claudia Sangalli, Kathrin Schuster, Beatrice M. Seddon, Morena Shkcodra, Eric L. Staals, William Tap, Matt van de Rijn, Kirsten van Langevelde, Filip M. M. Vanhoenacker, Andrew Wagner, Lisette Wiltink, Sydney Stern, Michiel Van de Sande, Sebastian Bauer
CANCER TREATMENT REVIEWS (2023)
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022
Christian Rothermundt, Dimosthenis Andreou, Jean-Yves Blay, Thomas Brodowicz, Ingrid M. E. Desar, Palma Dileo, Hans Gelderblom, Rick Haas, Jens Jakob, Robin L. Jones, Ian Judson, Wolfgang G. Kunz, Berndadette Liegl-Atzwanger, Lars H. Lindner, Christina Messiou, Aisha B. Miah, Peter Reichardt, Joanna Szkandera, Winette T. A. van der Graaf, Winan J. van Houdt, Eva Wardelmann, Silvia Hofer
EUROPEAN JOURNAL OF CANCER (2023)
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)
Emanuela Palmerini, Marco Gambarotti, Antoine Italiano, Michael J. Nathenson, Ravin Ratan, Palma Dileo, Salvatore Provenzano, Robin L. Jones, Steven G. DuBois, Javier Martin-Broto, Enrique de Alava, Giacomo G. Baldi, Giovanni Grignani, Virginia Ferraresi, Antonella Brunello, Luca Paoluzzi, Rossella Bertulli, Nadia Hindi, Michael Montemurro, Christian Rothermundt, Stefania Cocchi, Carmen Salguero-Aranda, Davide Donati, Juan D. Martin, Amr H. Abdelhamid Ahmed, Alessandro Mazzocca, Elisa Carretta, Marilena Cesari, Michela Pierini, Alberto Righi, Marta Sbaraglia, Maria A. Laginestra, Katia Scotlandi, Angelo P. Dei Tos, Toni Ibrahim, Silvia Stacchiotti, Bruno Vincenzi
EUROPEAN JOURNAL OF CANCER (2023)
Molecular profiling in desmoplastic small round cell tumours
Yuen Bun Tam, Robin L. Jones, Paul H. Huang
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2023)
The WID-EC test for the detection and risk prediction of endometrial cancer
James E. Barrett, Allison Jones, Iona Evans, Chiara Herzog, Daniel Reisel, Adeola Olaitan, Tim Mould, Nicola MacDonald, Konstantinos Doufekas, Claire Newton, Emma J. Crosbie, Line Bjorge, Nicoletta Colombo, Lukas Dostalek, Laura Costas, Paula Peremiquel-Trillas, Jordi Ponce, Xavier Matias-Guiu, Michal Zikan, David Cibula, Jiangrong Wang, Karin Sundstroem, Joakim Dillner, Martin Widschwendter
INTERNATIONAL JOURNAL OF CANCER (2023)
Pharmacotherapeutic strategies for epithelioid sarcoma: are we any closer to a non-surgical cure?
Magdalena Meissner, Andrea Napolitano, Khin Thway, Paul Huang, Robin L. Jones
EXPERT OPINION ON PHARMACOTHERAPY (2023)
Physical symptom burden in patients with desmoid-type fibromatosis and its impact on health-related quality of life and healthcare use
Anne-Rose W. Schut, Leanne E. de Bruin, Belle H. de Rooij, Emma Lidington, Milea J. M. Timbergen, Winette T. A. van Der Graaf, Winan J. van Houdt, Johannes J. Bonenkamp, Robin L. Jones, Dirk. J. Gruenhagen, Stefan Sleijfer, Spyridon Gennatas, Cornelis Verhoef, Olga Husson
CANCER MEDICINE (2023)
Optimal Delivery of Follow-Up Care Following Treatment for Adults Treated for Ewing Sarcoma
Antonia Digklia, Ana Dolcan, Monika A. Kucharczyk, Robin L. Jones, Andrea Napolitano
CANCER MANAGEMENT AND RESEARCH (2023)
A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma
Nam Bui, Hilary Dietz, Sheima Farag, Angela C. Hirbe, Michael J. Wagner, Brian A. Van Tine, Kristen Ganjoo, Robin L. Jones, Vicki L. Keedy, Elizabeth J. Davis
CANCERS (2023)
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Martin Kobel, Eun-Young Kang, Ashley Weir, Peter F. Rambau, Cheng-Han Lee, Gregg S. Nelson, Prafull Ghatage, Nicola S. Meagher, Marjorie J. Riggan, Jennifer Alsop, Michael S. Anglesio, Matthias W. Beckmann, Christiani Bisinotto, Michelle Boisen, Jessica Boros, Alison H. Brand, Angela Brooks-Wilson, Michael E. Carney, Penny Coulson, Madeleine Courtney-Brooks, Kara L. Cushing-Haugen, Cezary Cybulski, Suha Deen, Mona A. El-Bahrawy, Esther Elishaev, Ramona Erber, Sian Fereday, Anna Fischer, Simon A. Gayther, Arantzazu Barquin-Garcia, Aleksandra Gentry-Maharaj, C. Blake Gilks, Helena Gronwald, Marcel Grube, Paul R. Harnett, Holly R. Harris, Andreas D. Hartkopf, Arndt Hartmann, Alexander Hein, Joy Hendley, Brenda Y. Hernandez, Yajue Huang, Anna Jakubowska, Mercedes Jimenez-Linan, Michael E. Jones, Catherine J. Kennedy, Tomasz Kluz, Jennifer M. Koziak, Jaime Lesnock, Jenny Lester, Jan Lubinski, Teri A. Longacre, Maria Lycke, Constantina Mateoiu, Bryan M. McCauley, Valerie McGuire, Britta Ney, Alexander Olawaiye, Sandra Orsulic, Ana Osorio, Luis Paz-Ares, Teresa Ramon Y Cajal, Joseph H. Rothstein, Matthias Ruebner, Minouk J. Schoemaker, Mitul Shah, Raghwa Sharma, Mark E. Sherman, Yurii B. Shvetsov, Naveena Singh, Helen Steed, Sarah J. Storr, Aline Talhouk, Nadia Traficante, Chen Wang, Alice S. Whittemore, Martin Widschwendter, Lynne R. Wilkens, Stacey J. Winham, Javier Benitez, Andrew Berchuck, David D. Bowtell, Francisco J. Candido dos Reis, Ian Campbell, Linda S. Cook, Anna DeFazio, Jennifer A. Doherty, Peter A. Fasching, Renee T. Fortner, Maria J. Garcia, Marc T. Goodman, Ellen L. Goode, Jacek Gronwald, David G. Huntsman, Beth Y. Karlan, Linda E. Kelemen, Stefan Kommoss, Nhu D. Le, Stewart G. Martin, Usha Menon, Francesmary Modugno, Paul D. P. Pharoah, Joellen M. Schildkraut, Weiva Sieh, Annette Staebler, Karin Sundfeldt, Anthony J. Swerdlow, Susan J. Ramus, James D. Brenton
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2023)
The proteomic landscape of soft tissue sarcomas
Jessica P. Burns, Christopher Wilding, Lukas Krasny, Xixuan Zhu, Madhumeeta Chadha, Yuen Bun Tam, P. S. H. Hari, Aswanth Mahalingam, Alexander T. J. Lee, Amani Arthur, Nafia Guljar, Emma Perkins, Valeriya Pankova, Andrew Jenks, Vanessa Djabatey, Cornelia Szecsei, Frank McCarthy, Chanthirika Ragulan, Martina I. Milighetti, Theodoros Roumeliotis, Stephen Crosier, Martina S. Finetti, Jyoti Choudhary, Ian Judson, Cyril F. Fisher, Eugene Schuster, Anguraj W. Sadanandam, Tom Chen, Daniel Williamson, Khin L. Thway, Robin Jones, Maggie C. U. H. Cheang, Paul Huang
NATURE COMMUNICATIONS (2023)
Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas
Steven Attia, Victor Villalobos, Nadia Hindi, Andrew J. Wagner, Bartosz Chmielowski, Gerard J. Oakley, Patrick M. Peterson, Matteo Ceccarelli, Robin L. Jones, Mark A. Dickson
CANCERS (2023)
DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment
Chiara Herzog, Allison Jones, Iona Evans, Michal Zikan, David Cibula, Nadia Harbeck, Nicoletta Colombo, Angelique Floeter Radestad, Kristina Gemzell-Danielsson, Nora Pashayan, Martin Widschwendter
NPJ PRECISION ONCOLOGY (2023)